Drug rash with eosinophilia and systemic symptoms secondary to sulfasalazine

被引:16
|
作者
Rosenbaum, Jeremy [1 ]
Alex, George [1 ]
Roberts, Hugh [2 ]
Orchard, David [2 ]
机构
[1] Royal Childrens Hosp, Dept Gastroenterol, Melbourne, Vic 3052, Australia
[2] Royal Childrens Hosp, Dept Dermatol, Melbourne, Vic 3052, Australia
关键词
5-ASA; eosinophilia; drug reaction; hypersensitivity; rash; sulfasalazine; DRESS-SYNDROME; HYPERSENSITIVITY SYNDROME; MANAGEMENT;
D O I
10.1111/j.1440-1754.2009.01660.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
A severe cutaneous eruption in an unwell patient can be a major cause of physician anxiety. With numerous differential diagnoses, an early accurate diagnosis can be challenging. infectious causes are the most important to exclude in a timely manner and drug rash and eosinophilia with systemic symptoms (DRESS) is another differential diagnosis that should be considered in children. This hypersensitivity reaction is associated with multisystem involvement. Children with underlying chronic diseases may have impairment of normal metabolic pathways and are also often on multiple medications. Therefore, drugs should always be considered in the aetiopathology of any new symptoms and signs. This case report informs readers of the association of sulfasalazine and DRESS in an 11-year-old with inflammatory bowel disease and discusses its pathogenesis and treatment. Increased awareness of this disorder will hopefully lead to increased reporting and consequently illuminate the syndrome more clearly and help guide its prevention and treatment.
引用
收藏
页码:193 / 196
页数:4
相关论文
共 50 条
  • [31] Histopathology patterns of drug rash with eosinophilia and systemic symptoms syndrome
    Mirhossaini, Roya Brooke
    Hollingsworth, Parker
    Hu, Sophia
    Wolfe, Sophia M.
    Wissel, Joshua
    Newman, Sabrina
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB115 - AB115
  • [32] Leukapheresis in the management of drug rash with eosinophilia and systemic symptoms syndrome
    Martinez de Lagran, I.
    Marcos, P.
    Battle, M.
    Alonso, E.
    Plana, A.
    Tomasa, T.
    MEDICINA INTENSIVA, 2017, 41 (03) : 191 - 193
  • [33] Drug rash with eosinophilia and systemic symptoms induced by lamotrigine therapy
    Parri, N.
    Bernardini, R.
    Pucci, N.
    Novembre, E.
    Azzari, C.
    Vierucci, A.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2007, 20 (03) : 643 - 645
  • [34] Association of hypogammaglobulinemia with DRESS (Drug Rash with Eosinophilia and Systemic Symptoms)
    Boccara, Olivia
    Valeyrie-Allanore, Laurence
    Crickx, Beatrice
    Descamps, Vincent
    EUROPEAN JOURNAL OF DERMATOLOGY, 2006, 16 (06) : 666 - 668
  • [35] Drug reaction with eosinophilia and systemic symptoms without skin rash
    Sasidharanpillai, Sarita
    Binitha, Manikoth P.
    Manikath, Neeraj
    Janardhanan, Anisha K.
    INDIAN JOURNAL OF PHARMACOLOGY, 2015, 47 (06) : 687 - 689
  • [36] Drug rash with eosinophilia and systemic symptoms induced by cefotaxime and ampicillin
    Fujiwaki, Takehisa
    Yoshikawa, Tetsushi
    Urashima, Reiko
    Ishioka, Chihiro
    PEDIATRICS INTERNATIONAL, 2008, 50 (03) : 406 - 408
  • [37] Drug rash with eosinophilia and systemic symptoms (DRESS) due to streptomycin
    Passeron, T
    Ndir, MC
    Aubron, C
    Hovette, P
    ACTA DERMATO-VENEREOLOGICA, 2004, 84 (01) : 92 - 93
  • [38] Drug rash with eosinophilia and systemic symptoms syndrome:: The Dilemma of definition
    Daveluy, A.
    Miremont-Salame, G.
    Moore, N.
    Haramburu, F.
    DRUG SAFETY, 2007, 30 (10) : 981 - 982
  • [39] Drug Rash with Eosinophilia and Systemic Symptoms Syndrome Associated with Clindamycin
    Tian, David
    Mohan, Ram Jhingan
    Stallings, Gary
    AMERICAN JOURNAL OF MEDICINE, 2010, 123 (11): : E7 - E8
  • [40] DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) syndrome: description of two cases after administration of carbamazepine and sulfasalazine.
    Queyrel, V
    Catteau, B
    Michon-Pasturel, U
    Fauchais, AL
    Delcey, V
    Launay, D
    Legout, L
    Hachulla, E
    Hatron, PY
    Devulder, B
    REVUE DE MEDECINE INTERNE, 2001, 22 (06): : 582 - 586